Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Efficacy and Intermediate Endpoints Assays
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
NICEATM Support Contract: Optional Level of Effort
Development and regulation of stem cell lineages in skin
Development of a Biomarker for Dietary Furanocoumarins
Oxidative lipid stress in the brain
Growth Factors in Oxygen Injured Neonatal Eyes
Recently added grants:
Interplay between respiratory syncytial virus and nucleotide biosynthesis pathways
Autoimmunity to LINE-1-encoded antigens in SLE pathogenesis
IRGM proteins as regulators of inflammation
Secretory proteins of Cryptosporidium parvum
Host Ciracadian Clock and Malaria
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN43308-6-0-1
Application #
7587174
Study Section
Project Start
2004-05-15
Project End
2009-05-14
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Preclinical Efficacy and Intermediate Endpoints Assays
/ Washington University
$1,406,468
NIH 2007
N01 CA
Preclinical Efficacy and Intermediate Biomarker Assays
You, Ming /
$1,882,921
NIH 2007
N01 CA
Preclinical Efficacy and Intermediate Endpoints Assays
/
Comments
Be the first to comment on this grant